• NEW YORK, NY How do I update this listing?
Knoll Capital Management is based out of New York. Their last reported 13F filing for Q4 2019 included $135,430,000 in managed 13F securities and a top 10 holdings concentration of 91.35%. Knoll Capital Management's largest holding is Biohaven Pharmaceutical Holding Co Ltd with shares held of 857,494. Knoll Capital Management has met the qualifications for inclusion in our WhaleScore system. Whalewisdom has at least 49 13F filings, 2 13D filings, 45 13G filings, and 1 Form 4 filings